Home
> Mark Sulkowski

Mark Sulkowski

Mark Sulkowski

BiomedExperts Profile

Help us refine your profile

Profile

Trends

Research Network

Publications

1.
2013

Eric Lawitz; Jay P Lalezari; Tarek Hassanein; Kris V Kowdley; Fred F Poordad; Aasim M Sheikh; Nezam H Afdhal; David E Bernstein; Edwin Dejesus; Bradley Freilich; et al.

Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial.
The Lancet infectious diseases 2013;13(5):401-8.
2.
2013

Mark S Sulkowski

Current management of hepatitis C virus infection in patients with HIV co-infection.
The Journal of infectious diseases 2013;207 Suppl 1():S26-32.
3.
2013

Mark S Sulkowski; Fred Poordad; Michael P Manns; Jean-Pierre Bronowicki; K Rajender Reddy; Stephen A Harrison; Nezam H Afdhal; Heather L Sings; Lisa D Pedicone; Kenneth J Koury; et al.

Anemia during treatment with peginterferon Alfa-2b/ribavirin and boceprevir: Analysis from the serine protease inhibitor therapy 2 (SPRINT-2) trial.
Hepatology (Baltimore, Md.) 2013;57(3):974-84.

Similar Experts

Publications
David Thomas

234
Tsanyang Liang

163
Richard Moore

328
G. Subramanian

53
David Vlahov

606

Journals

Publications
AIDS (London, Englan...

16
Hepatology (Baltimor...

12
Journal of hepatolog...

10
Journal of viral hep...

8
Gastroenterology

8

Coauthor Network

Internal Coauthors

Shared Pub.
David Thomas

36
Richard Moore

18
Michael Torbenson

15
Richard Chaisson

8
Catherine Sutcliff...

7
G. Subramanian

6